|
|
||||||||
Department of Neurological Science, Royal Free Hospital, London, England (Drs. Newsom-Davis, Vincent, and Wilson): the Department of Biophysics, University College, London, England (Dr. Vincent); and the Department of Medicine, Postgraduate Medical School, Hammersmith Hospital, London, England (Dr. Pinching).
Plasma exchange has been used to investigate the function of antiacetylcholine receptor (anti-AChR) antibody in seven patients with acquired myasthenia gravis (MG) who had elevated antibody titers and in one patient with congenital MG who had normal titers. There was an inverse association between clinical indices of muscle strength and anti-AChR titers, with a minimum time lag of 2 days for the clinical response. The inverse association of the clinical state with anti-AChR antibody titers was closer than that with total immunoglobulin G or other immunoglobulins, and is consistent with the view that the anti-AChR antibody is the principal factor interfering with neuromuscular transmission in acquired MG.
Dr. Newsom-Davis' address is Department of Neurological Science, Royal Free Hospital, Pond Street, London NW3 2QG, England.
Accepted for publication November 9, 1977.
This article has been cited by other articles:
![]() |
W. F. Clark, G. A. Rock, N. Buskard, K. H. Shumak, P. LeBlond, D. Anderson, D. M. Sutton, and for the Canadian Apheresis Group* Therapeutic Plasma Exchange: An Update from the Canadian Apheresis Group Ann Intern Med, September 21, 1999; 131(6): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Besinger, K. Toyka, A. Anzil, A Fateh-Mognadam, R Rouscher, and K Heininger Myeloma neuropathy: passive transfer from man to mouse Science, August 28, 1981; 213(4511): 1027 - 1030. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |